Trending News

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

Supreme Court Clarifies Title VII Evidentiary Standards in “Reverse Discrimination” Cases, Removing Heightened Standard

“Supreme Court Shakes Things Up: Reversal of the ‘Background Circumstances’ Rule Marks Major Legal Shift”

SCOTUS Levels the Field for “Reverse” Discrimination: Potential Consequences

Supreme Court Invalidates "Background Circumstances" Rule in Title VII Cases

SCOTUS Unanimously Holds One Standard for Discrimination Cases Under Title VII

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial
Posted On Sunday, June 15, 2025
Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress
Posted On Sunday, June 15, 2025
Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor
Posted On Sunday, June 15, 2025
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
Posted On Saturday, June 14, 2025
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
Posted On Saturday, June 14, 2025
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
Posted On Friday, June 13, 2025
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
Posted On Friday, June 13, 2025
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, June 13, 2025
Sunset Social Club Opens as West Hollywood’s First Luxury Cannabis Lounge for Members Only
Posted On Friday, June 13, 2025
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
Posted On Friday, June 13, 2025
GT Biopharma Appoints New Member to its Board of Directors
Posted On Friday, June 13, 2025
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
Posted On Friday, June 13, 2025
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
Posted On Friday, June 13, 2025
Tiziana Life Sciences to Present at the Bio International Convention
Posted On Friday, June 13, 2025
Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
Posted On Friday, June 13, 2025
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025
Posted On Friday, June 13, 2025
Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025
Posted On Friday, June 13, 2025
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, June 13, 2025
Grace Therapeutics to Participate in the 2025 BIO International Conference
Posted On Friday, June 13, 2025
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
Posted On Friday, June 13, 2025
Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
Posted On Friday, June 13, 2025
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
Posted On Friday, June 13, 2025
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
Posted On Friday, June 13, 2025
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
Posted On Friday, June 13, 2025
ORLADEYO® (berotralstat) Approved in Colombia
Posted On Friday, June 13, 2025

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Print